Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing
Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial
Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Showing 20 of 53 results